Searching for selective cyclin-dependent kinase inhibitors to target the retinoblastoma/p16 cancer gene pathway.
A
A
Kubo
F J
FJ
Kaye
D000970:Antineoplastic Agents / Q000494:pharmacology*; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D016161:Genes, Retinoblastoma / Q000187:drug effects*; D006801:Humans; D010766:Phosphorylation / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; C423962:CINK4; D004791:Enzyme Inhibitors; D011743:Pyrimidines; D018844:Cyclin-Dependent Kinases